US2005142125A1PendingUtilityA1
Process for the preparation of protease inhibitor using novel alkalothermophilic Bacillus sp
Priority: Mar 31, 2000Filed: Dec 21, 2004Published: Jun 30, 2005
Est. expiryMar 31, 2020(expired)· nominal 20-yr term from priority
C12R 2001/07C07K 14/8142C12N 1/205A01N 63/22A01N 63/50
44
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention relates to a novel strain of alkalothermophilic Bacillus sp. isolated from a hot spring at Vajeshwari, District Thane, The State of Maharashtra, India and deposited at American Type Culture Centre (ATCC), bearing accession No. PTA 972, said strain of Bacillus sp. having the following characteristics (i) aerobic, (ii) gram positive, (iii) motile, (iv) spore forming, (v) capable of growing in a alkaline medium at pH 8-10, and (vi) exhibiting negative reaction towards production of indole, hydrogen, sulfide, ammonia and urease and positive reaction for hydrolysis of starch, production of catalase, hydrolysis of casein and reduction of nitrate.
Claims
exact text as granted — not AI-modified1 . An anti-fungae agent consisting of a low molecular weight alkaline protease inhibitor prepared according to the process of using alkalothermophilic Bacillus sp. deposited at ATCC at No.PTA-972, said process comprising the steps of :
i) growing the said strain of Bacillus sp. in a liquid fermentation medium containing assimilable carbon and nitrogen sources at a temperature in the range of 37-50° C. under aseptic conditions for a period of 24-48 hrs., ii) harvesting the culture broth, iii) separating the solids by conventional methods to obtain cell free liquid containing the protease inhibitor, iv) treating the cell free liquid with a decolourising agent, v) separating the decolourising agent and recovering the protease inhibitor by conventional methods.
2 . An anti-fungal agent as claimed in claim 1 , effective against fungi selected from Aspergillus sp., Alternaria sp., Fusarium sp., and Trichoderma sp.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.